Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT00129831 · COMPLETED
Trial details
- NCT number
- NCT00129831
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2005-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.